Why it matters that the human genome map was updated and what biotech’s doing about food allergies—plus, breaking news about the BIO International Convention keynote speaker. (656 words, 3 minutes, 16 seconds)
We sat down with BIO experts to take a deep dive into the new EU pharma reform package—here’s what you need to know. Plus, to kick off National Women’s Health Week, Bio.News and the CDC have three steps to better health. (624 words, 3 minutes, 7 seconds)
Ending the week with a step forward on PBM reform, and a look at how climate change is impacting our health in more ways than one. (508 words, 2 minutes, 32 seconds)
Two hearings yesterday highlighted incredible biopharmaceutical advances and how policy can help or hinder access to them. Plus, BIO Impact registration is now open—here’s what you need to know. (741 words, 3 minutes, 42 seconds)
BIO’s comments focus on two areas that threaten patient access to innovative medicines in Medicare: (1) the anti-innovation policies enacted as part of the Inflation Reduction Act, and (2) government policies that that are blocking patient access to new FDA-approved treatments.
The AIM for Climate Summit wraps up in Washington, D.C., with calls for investment in the bioeconomy. Plus, we’re watching for ticks—and new Lyme disease treatments and vaccines. (677 words, 3 minutes, 23 seconds)
On today’s new episode of the I am BIO Podcast, FDA Commissioner Dr. Robert Califf explains why misinformation is deadly. Plus, BIO CEO Rachel King explains why we need to help SAF take off. (547 words, 2 minutes, 44 seconds)
